Business

Bio-Techne Q4 revenue beats forecasts, earnings in line
Life sciences firm Bio-Techne posted fourth-quarter revenue above analyst estimates while earnings matched expectations. Shares were indicated higher in extended trading.

Ituran posts record Q2 revenue, beats estimates
Israel-based vehicle tracking firm Ituran reported a 21% year-over-year revenue increase in Q2, topping analyst forecasts with record sales.

Coca-Cola İçecek Q2 2026 margin gains driven by international sales
Turkish bottler reports improved profitability in Q2 2026 as international demand offsets regional pressures. Slides highlight volume growth and cost efficiencies.

Helios Q2 2026 outlook raised on double-digit growth
Slide deck shows continued revenue expansion and upgraded guidance for the next fiscal year.

TD SYNNEX expands IBM hardware distribution to 20 new countries
Tech distributor TD SYNNEX secures IBM partnership to broaden global reach for servers, storage and AI infrastructure.

Middleby reports Q2 profit beat, revenue exceeds forecasts
Food equipment maker Middleby posts adjusted EPS of $4.21, topping expectations by $0.39, as sales rise 8% year-over-year.

Elanco gains FDA nod for screwworm treatment
U.S. regulator grants emergency authorization for Elanco’s topical spray to combat New World screwworm infestations in livestock.

US energy firms' earnings meet forecasts, revenue beats estimates
Major U.S. energy companies reported quarterly results that matched profit expectations while revenue exceeded analyst projections, supported by stable oil prices and operational efficiency gains.

Liquidia earnings, YUTREPIA patent test loom for biotech
Biotech firm Liquidia reports quarterly results as its pulmonary arterial hypertension drug faces a critical patent challenge. Analysts weigh revenue outlook amid legal uncertainty.

ATAI Life Sciences to report earnings amid Eli Lilly deal scrutiny
Investors await ATAI Life Sciences' earnings report as speculation grows over a potential partnership with Eli Lilly, following recent biotech sector deal activity.

Super Micro Computer earnings preview: Margins in focus after revenue miss
Investors will scrutinize margins as Super Micro Computer reports quarterly results amid concerns over revenue growth and cost pressures.

Brinker International Q4 earnings, FY27 outlook in focus
Restaurant operator Brinker International reports quarterly results amid investor scrutiny of its full-year 2027 guidance. Analysts weigh margin trends and consumer demand signals.

Franco-Nevada Q2 earnings in focus as gold price swings test royalty model
Gold price volatility over the past quarter may pressure Franco-Nevada's earnings growth despite its diversified royalty portfolio.

Performance Food Group shares rise ahead of quarterly earnings report
Food distributor faces investor scrutiny as it prepares to release quarterly results on Wednesday, with shares gaining modestly in pre-market trading.

CoreWeave earnings preview: AI infrastructure drives profit outlook
AI-focused data center operator CoreWeave reports earnings as demand for high-performance computing accelerates amid AI infrastructure buildout.

Sitowise Q2 2025 earnings mixed, shares fall
Finnish engineering firm's quarterly results miss expectations as revenue growth slows and costs rise. Shares decline in early trading.

Chicago Atlantic outlines Q2 2026 merger plans amid regulatory reform
Real estate investment firm Chicago Atlantic details merger strategy for Q2 2026, positioning plans within evolving U.S. regulatory framework for financial services.

Vestis Q3 2026 profitability rises as volume strategy shifts
Slides reveal improved margins despite strategic pivot in sales approach. Full results due Nov 10.

DCM eyes 30%+ growth in IDP market via Octacom acquisition
Private equity firm DCM plans to expand its Intelligent Document Processing portfolio with the Octacom buyout, targeting over 30% market share growth in Q2 2026.

Nebius earnings eyed as Vineland pushes back test phase
Vineland's delay in test execution raises questions ahead of Nebius's earnings report. Investors assess impact on projected timelines.

Lumentum earnings to show AI optics demand, profitability test
Optical components supplier Lumentum faces scrutiny on margins as AI-driven demand for high-end lasers and photonic chips tests its profitability in the latest quarter.

Duffy highlights telecom disruptions after Trump helicopter incident
U.S. Senator Mike Duffy acknowledges potential infrastructure damage following a helicopter incident near a telecom facility, raising concerns over service reliability.

Mineralys Therapeutics losses seen widening in next earnings
Biopharma firm reports revenue growth but deeper losses expected as R&D costs rise. Analysts project Q2 net loss of $0.25 per share.

Firefly Aerospace earnings to highlight lunar contract focus
Space launch firm’s results expected to underscore growing role in NASA’s lunar missions amid rising commercial space activity.

PagSeguro Q2 earnings in focus as credit growth slows
Brazil’s fintech faces scrutiny over loan book expansion amid rising delinquencies and macroeconomic headwinds. Results due Aug 8.

